Free Trial

Banco Bilbao Vizcaya Argentaria S.A. Grows Stock Position in Synopsys, Inc. $SNPS

Synopsys logo with Computer and Technology background

Key Points

  • Banco Bilbao Vizcaya Argentaria S.A. increased its stake in Synopsys, Inc. by 5.7%, acquiring an additional 990 shares, bringing its total holdings to 18,388 shares valued at approximately $7.9 million.
  • Thirteen research analysts have rated Synopsys with a Buy rating, with a consensus target price of $630.67, reflecting strong confidence in the company's performance.
  • CEO Sassine Ghazi sold 11,366 shares of Synopsys stock recently, resulting in a significant decrease in ownership, while corporate insiders have sold over $13 million in shares in the past ninety days.
  • Need better tools to track Synopsys? Try 5 Weeks of MarketBeat All Access for $5. Start Portfolio Tracking Now.

Banco Bilbao Vizcaya Argentaria S.A. lifted its stake in Synopsys, Inc. (NASDAQ:SNPS - Free Report) by 5.7% in the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 18,388 shares of the semiconductor company's stock after purchasing an additional 990 shares during the quarter. Banco Bilbao Vizcaya Argentaria S.A.'s holdings in Synopsys were worth $7,918,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently modified their holdings of SNPS. Brighton Jones LLC raised its position in shares of Synopsys by 5.7% in the 4th quarter. Brighton Jones LLC now owns 921 shares of the semiconductor company's stock valued at $447,000 after purchasing an additional 50 shares during the last quarter. XTX Topco Ltd purchased a new position in shares of Synopsys in the 4th quarter valued at approximately $228,000. Jump Financial LLC purchased a new position in shares of Synopsys in the 4th quarter valued at approximately $453,000. NewEdge Advisors LLC raised its position in shares of Synopsys by 5.1% in the 4th quarter. NewEdge Advisors LLC now owns 2,615 shares of the semiconductor company's stock valued at $1,269,000 after purchasing an additional 127 shares during the last quarter. Finally, Kayne Anderson Rudnick Investment Management LLC raised its position in shares of Synopsys by 516.0% in the 4th quarter. Kayne Anderson Rudnick Investment Management LLC now owns 154 shares of the semiconductor company's stock valued at $75,000 after purchasing an additional 129 shares during the last quarter. 85.47% of the stock is owned by hedge funds and other institutional investors.

Insider Activity

In other news, CEO Sassine Ghazi sold 11,366 shares of the stock in a transaction that occurred on Monday, June 2nd. The stock was sold at an average price of $457.93, for a total transaction of $5,204,832.38. Following the transaction, the chief executive officer owned 71,589 shares in the company, valued at $32,782,750.77. This trade represents a 13.70% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, CRO Richard S. Mahoney sold 9,010 shares of the stock in a transaction that occurred on Wednesday, June 18th. The shares were sold at an average price of $471.21, for a total value of $4,245,602.10. Following the transaction, the executive owned 1,485 shares in the company, valued at $699,746.85. This trade represents a 85.85% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 27,686 shares of company stock worth $13,001,048 in the last quarter. Corporate insiders own 0.62% of the company's stock.

Wall Street Analysts Forecast Growth

Several brokerages recently commented on SNPS. Stifel Nicolaus set a $550.00 price objective on shares of Synopsys in a research report on Monday, April 28th. Piper Sandler increased their price target on shares of Synopsys from $615.00 to $660.00 and gave the stock an "overweight" rating in a report on Monday, July 21st. Bank of America increased their price target on shares of Synopsys from $575.00 to $625.00 and gave the stock a "buy" rating in a report on Wednesday, July 16th. Needham & Company LLC reiterated a "buy" rating and issued a $660.00 price target (up previously from $650.00) on shares of Synopsys in a report on Tuesday, July 15th. Finally, Morgan Stanley reiterated an "overweight" rating and issued a $715.00 price target (up previously from $540.00) on shares of Synopsys in a report on Monday, August 11th. Twelve investment analysts have rated the stock with a Buy rating and one has given a Hold rating to the company's stock. According to data from MarketBeat.com, Synopsys presently has a consensus rating of "Moderate Buy" and an average target price of $626.79.

View Our Latest Research Report on SNPS

Synopsys Stock Performance

Shares of NASDAQ SNPS traded up $8.35 during midday trading on Friday, reaching $606.52. 863,153 shares of the stock were exchanged, compared to its average volume of 1,313,433. The firm has a market cap of $94.11 billion, a price-to-earnings ratio of 43.79, a PEG ratio of 3.93 and a beta of 1.15. Synopsys, Inc. has a twelve month low of $365.74 and a twelve month high of $651.73. The firm has a 50-day simple moving average of $570.29 and a two-hundred day simple moving average of $500.95. The company has a quick ratio of 6.85, a current ratio of 7.02 and a debt-to-equity ratio of 1.01.

Synopsys (NASDAQ:SNPS - Get Free Report) last issued its quarterly earnings data on Wednesday, May 28th. The semiconductor company reported $3.67 EPS for the quarter, topping analysts' consensus estimates of $3.40 by $0.27. The business had revenue of $1.60 billion for the quarter, compared to analysts' expectations of $1.60 billion. Synopsys had a net margin of 34.77% and a return on equity of 17.09%. The business's revenue was up 10.3% on a year-over-year basis. During the same quarter last year, the company earned $3.00 EPS. Synopsys has set its FY 2025 guidance at 15.110-15.190 EPS. Q3 2025 guidance at 3.820-3.87 EPS. As a group, analysts anticipate that Synopsys, Inc. will post 10.64 EPS for the current fiscal year.

Synopsys Company Profile

(Free Report)

Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.

Read More

Institutional Ownership by Quarter for Synopsys (NASDAQ:SNPS)

Should You Invest $1,000 in Synopsys Right Now?

Before you consider Synopsys, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Synopsys wasn't on the list.

While Synopsys currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Next Tech Boom: AI Robots Are Coming Sooner Than You Think!
Tech Stocks Stumble: Will Nvidia’s Report Spark a Rebound?
Follow the Money: 5 Stocks Institutions Are Buying NOW

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines